Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…

People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…

Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…

"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…

The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …

"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…

Eli Lilly's tirzepatide weight-loss drug just got FDA approval. It is cheaper and possibly more eff…

Eli Lilly now sports a market valuation of about $500 billion, making it the ninth largest US compa…

Tirzepatide, marketed as Mounjaro for diabetes, could soon become the latest weight loss drug to be…

These are Insider's biggest healthcare stories for the week ending July 16.

A weekly intake of a drug, approved to treat Type 2 diabetes, can provide substantial and sustained…

The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial,…

Viking Therapeutics' experimental drug helped patients lose weight faster than other popular GLP-1 …

Using tirzepatide for weight loss was most effective with diet and exercise changes. It may be more…

Zepbound can help people lose significant amounts of weight, but may need to be taken long-term to …

Popular weight-loss injections including tirzepatide, semaglutide, and liraglutide all work to regu…

In a new study, patients on tirzepatide (Mounjaro) lost nearly 16% of their body weight in 16 month…

A new study suggests Mounjaro is a stronger and more potent drug for weight loss than Ozempic — ove…

Patients and doctors share their perspectives on the biggest ever revolution in obesity medicine.

New weight loss drug retatrutide works on hormones linked to appetite and calorie burning and may b…